Article
Structural basis of SARS-CoV-2 polymerase inhibition by Favipiravir
2020-10-19
Abstract excerpt
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into an unprecedented global pandemic. Nucleoside analogues, such as Remdesivir and Favipiravir, can serve as the first-line broad-spectrum antiviral drugs against the newly emerging viral diseases. Recent clinical trials of these two drugs for SARS-CoV-2 treatment revealed antiviral efficacies as well as side effects with d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 54aec1ad-f1a7-59ff-a1a6-4c967b6db45f
- DOI
- 10.1101/2020.10.19.345470
